The study identifies bioactive compounds in Euphorbia tirucalli, affecting Jurkat cells, suggesting therapeutic potential.
Building on our previous studies, the aerial parts of Vietnamese Euphorbia tirucalli were analysed for their phytochemistry via headspace gas chromatography-mass spectrometry, column chromatography, and thin-layer chromatography. From the EA extract, 25 compounds were isolated and structurally elucidated via nuclear magnetic resonance spectroscopy and high-resolution mass spectrometry, including a new tirucallane triterpenoid (tirucallenone A, (1)). The PE extract was found to be the most effective against Jurkat cells (IC₅₀ = 22.38 μg.mL⁻¹), while the aqueous extract was revealed to exhibit the highest α-glucosidase inhibitory capacity (IeC₅₀ = 115.80 μg.mL⁻¹) and the highest intracellular ROS scavenging activity (S = 61.41%). The ROS scavenging and apoptosis-inducing effect studies on Jurkat cells indicated that these cells were killed via the sub-G1 cells accumulation, nuclei fragmentation, and intracellular oxidative stress modulation. Besides, gallic and 3,3',4'-tri-O-methylellagic acids were the most notable in cytotoxicity against Jurkat cells (IC₅₀ = 31.68 and 66.41 μM, respectively).
No takes yet. Share an insight, caveat, or question.
Vu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: